Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93
Tectonic Therapeutic Inc
Tectonic Therapeutic Inc TECX | 0.00 |
Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:
TECX) with a Overweight and lowers the price target from $101 to $93.
